Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 2OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Rectal Neoplasms 2Leukemia 2Colonic Neoplasms 2Breast Neoplasms 2Oligodendroglioma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Astrocytoma 1

Interventions

Radiotherapy 30Temozolomide 16Carboplatin 16Chemotherapy, Adjuvant 15Cisplatin 13Vincristine 12Magnetic Resonance Spectroscopy 12Cyclophosphamide 11Etoposide 10Carmustine 10Methotrexate 8Specimen Handling 7Peripheral Blood Stem Cell Transplantation 7Filgrastim 7X-Rays 6Thiotepa 6Surgical Procedures, Operative 6Phantoms, Imaging 6O(6)-benzylguanine 6Lomustine 6Biopsy 6motexafin gadolinium 4Nuclear Medicine Department, Hospital 4Drug Therapy 4Tamoxifen 3Psychiatric Rehabilitation 3Procarbazine 3Neoadjuvant Therapy 3Mental Status and Dementia Tests 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Central Nervous System Neoplasms × In Situ Hybridization, Fluorescence × Clear all
NCT00360945 2013-09-17

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

National Cancer Institute (NCI)

Phase 2 Unknown
87 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡